Standard BioTools Inc

$1.95 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Standard BioTools Inc

Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

Stock Analysis

last close $1.95
1-mo return -36.3%
3-mo return -46.1%
avg daily vol. 1.06M
52-week high 7.51
52-week low 1.85
market cap. $172M
forward pe -
annual div. -
roe -160.9%
ltg forecast -
dividend yield -
annual rev. $124M
inst own. 94.3%

Subscribe now for daily local and international financial news